Delivery Order SPE2DB22D2006-SPE2DB24FW1NC
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,660.67 Firm Fixed Price Delivery Order contract is for the supply of 4567394215 ! VYVANSE 70 MG CAPSULE 100S. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $9,063.85 firm fixed-price delivery order was awarded on May 20, 2024 with a completion date of May 21, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025 with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,276.50, has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this contract without any set-aside designation, indicating it was a full and open competition. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VYVANSE 30 MG CAPSULE 100S. The contract, valued at $5,441.66, is a firm fixed price delivery order with a period of performance through November 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Vyvanse 50 mg capsules. The $1,825.48 firm fixed-price delivery order has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VYVANSE 40 MG CAPSULE 100S. The $2,449.75 Firm Fixed Price contract has a completion date of February 12, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $1,068.99 and is set to expire on April 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,024.88 and a period of performance through May 2, 2024. It is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,520.95, placed under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the provision of VYVANSE 30 MG CAPSULE 100S, a prescription medication, to support the Department of Defense's medical requirements. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award IDC with the DLA valued up to...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The award, valued at $2,646.64, is a Firm Fixed Price Delivery Order contract without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025....